There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
We aim to investigate the association between angiotensin-converting enzyme inhibitors
(ACEIs)/angiotensin receptor blockers (ARBs) therapy and colorectal cancer (CRC) by
conducting a systematic review with meta-analysis.
[1
]
Department of Gastroenterology, The First Affiliated Hospital, College of Medicine,
Zhejiang University, No. 79 Qingchun Road, Hangzhou, Zhejiang, China.